Success Stories: EB-1B Petition Approved in Just 36 Days for a Scientist in the Field of Pharmaceutical Sciences, Thanks to Premium Processing

 

Client’s Testimonial:

"Thank you very much for all your kind support and in-time responses. We will be very grateful to you for all your continued support and valuable time.”


On March 11th, 2021, we received another EB-1B (Outstanding Professors and Researchers) approval for a Scientist in the Field of Pharmaceutical Sciences (Approval Notice).


General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Scientist

Country of Origin: India

Approval Notice Date: March, 2021

Processing Time: 36 days (Premium Processing Requested)


Case Summary:

A Scientist from India equipped with a Ph.D. in pharmaceutics contacted North America Immigration Law Group to help - document an EB-1B (Outstanding Professors and Researchers) petition. Our legal team began filing the EB-1B case on her behalf as soon as her employer-provided us with the required testimonies to file the petition. Her employer supported her to the fullest as the EB-1B is an employer-sponsored visa category.

We incorporated the below-mentioned attributes in her petition packet:

  • We elaborated on our client’s research focusing on developing novel drug delivery and tissue engineering strategies. We concluded that her research addresses some of our nation’s most pressing issues in understanding the best approaches to fibrosis and intracranial disorders.
  • Several of her research experiences have well-prepared her to make a number of field-leading breakthroughs, and are very well-documented by reviewing her publication record and the extensive number of citations that her work has received from fellow professionals. Thus, we detailed our client’s more than 5 peer-reviewed scientific articles that had amassed more than 90 citations. Moreover, she conducted 6 reviews of her peers, demonstrating her significant impact on the pharmaceutical science field.
  • To make our client’s EB-1B case stronger, we included four recommendation letters she obtained from other top-level researchers in the field. One of her recommenders expressed:
“[Client] has positioned herself to continue making major breakthroughs in pharmaceutical sciences research, supplementing the already strong reputation that she has created over the span of her career. I can confidently confirm that she has attained a leading level of influence and acclaim in our mutual discipline, and her ongoing breakthroughs are paramount to its continued progress.”

Premium processing service has yet again proved to be a great aid to the client’s case as her EB-1B petition was approved by the USCIS within 36 days, without an RFE. It was a pleasure working with our client, and we would like to congratulate her on this milestone.